1. Home
  2. BEAT vs CAPN Comparison

BEAT vs CAPN Comparison

Compare BEAT & CAPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • CAPN
  • Stock Information
  • Founded
  • BEAT 2015
  • CAPN 2024
  • Country
  • BEAT United States
  • CAPN United States
  • Employees
  • BEAT N/A
  • CAPN N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • CAPN
  • Sector
  • BEAT Technology
  • CAPN
  • Exchange
  • BEAT Nasdaq
  • CAPN NYSE
  • Market Cap
  • BEAT 74.1M
  • CAPN 78.7M
  • IPO Year
  • BEAT 2021
  • CAPN 2024
  • Fundamental
  • Price
  • BEAT $2.14
  • CAPN $10.06
  • Analyst Decision
  • BEAT Buy
  • CAPN
  • Analyst Count
  • BEAT 1
  • CAPN 0
  • Target Price
  • BEAT $8.00
  • CAPN N/A
  • AVG Volume (30 Days)
  • BEAT 117.1K
  • CAPN 4.7K
  • Earning Date
  • BEAT 11-07-2024
  • CAPN 01-01-0001
  • Dividend Yield
  • BEAT N/A
  • CAPN N/A
  • EPS Growth
  • BEAT N/A
  • CAPN N/A
  • EPS
  • BEAT N/A
  • CAPN N/A
  • Revenue
  • BEAT N/A
  • CAPN N/A
  • Revenue This Year
  • BEAT N/A
  • CAPN N/A
  • Revenue Next Year
  • BEAT N/A
  • CAPN N/A
  • P/E Ratio
  • BEAT N/A
  • CAPN N/A
  • Revenue Growth
  • BEAT N/A
  • CAPN N/A
  • 52 Week Low
  • BEAT $1.35
  • CAPN $10.12
  • 52 Week High
  • BEAT $3.48
  • CAPN $10.25
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 39.59
  • CAPN N/A
  • Support Level
  • BEAT $2.00
  • CAPN N/A
  • Resistance Level
  • BEAT $2.30
  • CAPN N/A
  • Average True Range (ATR)
  • BEAT 0.16
  • CAPN 0.00
  • MACD
  • BEAT -0.00
  • CAPN 0.00
  • Stochastic Oscillator
  • BEAT 35.00
  • CAPN 0.00

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About CAPN CAYSON ACQUISITION CORP

Cayson Acquisition Corp is a blank check company.

Share on Social Networks: